OMEICOS

OMEICOS develops and commercializes small molecule therapeutics for the treatment of cardiovascular, fatty liver and bronchial diseases.

Business Model:

Revenue: $1.2M

Employees: 11-50

Rankings

Detailed OMEICOS Information

Geographic Data

OMEICOS headquarters map

Address: Robert-Rössle-Strasse 10

City: Berlin

State: baden-württemberg

Zip: 13125

Country: DE

Financial Info

Stage:

series c

Raised Last:

$19M

Raised Total:

$37M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

OMEICOS develops and commercializes small molecule therapeutics for the treatment of cardiovascular, fatty liver and bronchial diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2018 Series C $0 Forbion Capital Partners
High-Tech Grunderfonds
KfW
KG Investments
Remiges Ventures
SICAR
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
Forbion Capital Partners
High-Tech Grunderfonds
KfW
KG Investments
Remiges Ventures
SICAR
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
2/2017 Series B $8.8M Vesalius Biocapital
KFW Group
High-Tech Gründerfonds
10/2017 Series B -
3/2017 Series B $0 Ascenion GmbH
KfW
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
Ascenion GmbH
KfW
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
6/2017 Grant 1 $1.9M German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)
4/2015 Series A $6.6M Vesalius Biocapital
High-Tech Gründerfonds
12/2013 Seed Round 1 $675k High-Tech Grunderfonds
High-Tech Grunderfonds
4/2015 Series A $0 High-Tech Grunderfonds
IBB Ventures
KfW
SMSgroup
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
High-Tech Grunderfonds
IBB Ventures
KfW
SMSgroup
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
10/2017 Series B 1 - Remiges Ventures
Remiges Ventures
11/2015 Grant $1.9M Federal Ministry of Education and Research
11/2018 Series C $19.3M Forbion
Vesalius Biocapital II S.A
Remiges BioPharma Fund
SMS group GmbH
KfW Group
High-Tech Gründerfonds Management GmbH
10/2017 Series B - REMIGES Ventures
REMIGES Ventures
11/2018 Series C 10 $19.4M Forbion Capital Partners
High-Tech Grunderfonds
KfW
KG Investments
Remiges Ventures
SICAR
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
Forbion Capital Partners
High-Tech Grunderfonds
KfW
KG Investments
Remiges Ventures
SICAR
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
10/2017 Series B 1 - Remiges Ventures
Remiges Ventures
3/2017 Series B 6 $8.7M Ascenion GmbH
KfW
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
Ascenion GmbH
KfW
SMSgroup
The Falck Revocable Trust
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
4/2015 Series A 6 $6.6M High-Tech Grunderfonds
IBB Ventures
KfW
SMSgroup
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
High-Tech Grunderfonds
IBB Ventures
KfW
SMSgroup
VC Fonds Technologie Berlin
Vesalius Biocapital Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research